Kenneth Bate [Member] Kenneth Bate Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Variable Rate [Domain] Variable Rate [Domain] Pay vs Performance Disclosure [Line Items] Entity Voluntary Filers Entity Voluntary Filers Schedule of Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Accrued expenses Total accrued liabilities Accrued Liabilities, Current Range [Domain] Statistical Measurement [Domain] Line of credit facility, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Unrealized loss on investment Deferred Tax Asset, Debt Securities, Trading, Unrealized Loss Expiration period Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Equity Award [Domain] Award Type [Domain] Fair Value as of Grant Date Award Grant Date Fair Value Equity instruments other than options, outstanding (in shares) Unvested, beginning balance (in shares) Unvested, ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Line of credit facility, interest rate Line of Credit Facility, Interest Rate at Period End Long Term Debt Debt Disclosure [Text Block] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Research and Development Costs Research and Development Expense, Policy [Policy Text Block] Summary of Cash, Cash Equivalents and Investments Cash, Cash Equivalents and Investments [Table Text Block] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Performance-based restricted stock units Performance Shares [Member] Accounts payable Accounts Payable, Current Exercisable at the end of the year Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Restatement Determination Date: Restatement Determination Date [Axis] Corporate debt securities due within 1 year of date of purchase Corporate Debt Securities [Member] Insider Trading Policies and Procedures [Line Items] Exercisable at the end of the year (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Proceeds from issuance or sale of equity Proceeds from Issuance or Sale of Equity Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Variable Rate Component One Variable Rate Component One [Member] Variable Rate Component One Stockholders' Equity Equity [Text Block] Proceeds from issuance of common stock, net Proceeds from Issuance of Common Stock Sale of stock, minimum required percentage of ownership after transaction Class Of Warrant Or Right, Beneficial Ownership, Exercise Threshold Class Of Warrant Or Right, Beneficial Ownership, Exercise Threshold Accrued Liabilities, Current [Abstract] Accrued Liabilities, Current [Abstract] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Income Taxes Income Tax Disclosure [Text Block] Current liabilities: Liabilities, Current [Abstract] Increase in domestic valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Preferred stock, par value $0.0001 per share authorized: 5,000,000 shares at December 31, 2023 and December 31, 2022; 2,369,797 and 2,369,797 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively Preferred Stock, Value, Issued Weighted average grant date fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Diluted net loss per common share (in dollars per share) Earnings Per Share, Diluted Schedule of Investments [Table] Schedule of Investments [Table] PEO Total Compensation Amount PEO Total Compensation Amount Loan Facility, Tranche 4 Loan Facility, Tranche Four [Member] Loan Facility, Tranche Four Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Line of Credit Line of Credit [Member] Beginning balance (in shares) Ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Sale of common shares to related parties and exercise of common stock options, net of transaction costs Stock Issued During Period, Value, Stock Options Exercised Trading Symbol Trading Symbol Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Options granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted-average grant date fair value of options (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Net loss Net Loss Net loss Net Income (Loss) Total current liabilities Liabilities, Current Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Company Selected Measure Name Company Selected Measure Name Leases Lessee, Operating Leases [Text Block] Common stock reserved for future issuance amount Common Stock, Capital Shares Reserved for Future Issuance, Amount Common Stock, Capital Shares Reserved for Future Issuance, Amount 2020 Sales Agreement Two Thousand and Twenty Sales Agreement [Member] Two Thousand and Twenty Sales Agreement Liabilities and Stockholders’ Equity Liabilities and Equity [Abstract] Stock price discount per common share (in dollars per share) Class Of Warrant Or Right, Stock Price Discount Per Common Share Class Of Warrant Or Right, Stock Price Discount Per Common Share Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Stockholders’ equity: Equity, Attributable to Parent [Abstract] Unrealized losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Sale of common shares to related parties and exercise of common stock options, net of transaction costs ( in shares) Options exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Executive Category: Executive Category [Axis] Comprehensive Loss Comprehensive Income, Policy [Policy Text Block] Other Commitments [Table] Other Commitments [Table] Options exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Name Measure Name Total deferred tax assets Deferred Tax Assets, Net of Valuation Allowance Name Forgone Recovery, Individual Name Hercules warrant Adjustments to Additional Paid in Capital, Warrant Issued Equity Components [Axis] Equity Components [Axis] Exercise price of warrants (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Major Types of Debt and Equity Securities [Domain] Financial Instruments [Domain] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Accrued expense Increase (Decrease) in Accrued Liabilities Shares available for future issuance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant 2025 Long-Term Debt, Maturity, Year Two Options granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Underlying Securities Award Underlying Securities Amount Entity Small Business Entity Small Business Local Phone Number Local Phone Number James Daly [Member] James Daly Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Warrants Warrant [Member] Lease liability Operating Lease, Liability, Noncurrent Restricted stock units Restricted Stock Units (RSUs) [Member] Summary of restricted stock unit activity Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Accounts payable Increase (Decrease) in Accounts Payable, Trade Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Aggregate intrinsic value (in thousands) Share Based Compensation Arrangement by Share Based Payment Award, Options Outstanding Aggregate Intrinsic Value [Abstract] Share Based Compensation Arrangement by Share Based Payment Award, Options Outstanding Aggregate Intrinsic Value [Abstract] Stock based compensation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount Payment of debt issuance costs Payments of Debt Issuance Costs Income Statement Location [Axis] Income Statement Location [Axis] Arrangements and Non-arrangement Transactions [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Research and development Research and Development Expense (Excluding Acquired in Process Cost) Patent expenses Patent Costs The amount of costs to secure and defend patents expenses in the statements of operations. Schedule of Future Minimum Payments for Operating Leases Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Number of votes per share that common stockholders are entitled to receive Common Stock Voting Rights Number Represents the number of votes per share that common stockholders are entitled to receive. Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Sale of stock, number of shares issued in transaction (in shares) Sale of Stock, Number of Shares Issued in Transaction Liquidity and Uncertainties Substantial Doubt about Going Concern [Text Block] Total revenues Revenues Revenues Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Other Performance Measure, Amount Other Performance Measure, Amount Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Research and development Research and Development Expense [Member] Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Proceeds from issuance of common stock, gross Sale Of Stock, Consideration Received On Transaction, Gross Sale Of Stock, Consideration Received On Transaction, Gross Manufacturing and drug supply Accrued Manufacturing and Drug Supply Current Accrued manufacturing and drug supply Current. Award Type [Axis] Award Type [Axis] Antidilutive securities excluded from computation of earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Plan Name [Domain] Plan Name [Domain] Interest expense Interest Expense ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag General and administrative General and Administrative Expense [Member] Quarterly Financial Data (unaudited) Quarterly Financial Information [Text Block] Outstanding at the end of the year Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Obtaining a right-of-use asset in exchange for a lease liability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Trading Arrangement: Trading Arrangement [Axis] Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Table] Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Use of Estimates Use of Estimates, Policy [Policy Text Block] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Cost Cash, Cash Equivalents, and Short-term Investments, At Cost This item represents the cost of debt and equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings, and cash and cash equivalents. Long-Term Debt, Type [Domain] Long-Term Debt, Type [Domain] Marketable securities: Debt Securities, Available-for-Sale [Abstract] Entity File Number Entity File Number Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Income Taxes Operating Loss Carryforwards [Line Items] Less unamortized discount Debt Instrument, Unamortized Discount Lease liability Operating Lease, Liability, Current 2026 Long-Term Debt, Maturity, Year Three Capitalized R&D Deferred Tax Assets, Deferred Expense, Capitalized Research and Development Costs Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from research and development costs. Auditor Firm ID Auditor Firm ID Sales and maturities of marketable securities Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale Entity Shell Company Entity Shell Company 2026 Lessee, Operating Lease, Liability, to be Paid, Year Three Line of credit facility, increase (decrease) Line of Credit Facility, Increase (Decrease), Net Recent Accounting Pronouncements Not Yet Adopted New Accounting Pronouncements, Policy [Policy Text Block] Restatement Determination Date Restatement Determination Date Loan Facility, Tranches 2 and 3 Loan Facility, Tranches Two and Three [Member] Loan Facility, Tranches Two and Three Paul Friedman [Member] Paul Friedman Counterparty Name [Domain] Counterparty Name [Domain] Line of credit facility, increase In maximum borrowing capacity Line Of Credit Facility, Increase In Maximum Borrowing Capacity Line Of Credit Facility, Increase In Maximum Borrowing Capacity Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Minimum liquidity covenant Debt Instrument, Covenant, Liquidity, Minimum Debt Instrument, Covenant, Liquidity, Minimum 2025 Lessee, Operating Lease, Liability, to be Paid, Year Two Liquidity and Uncertainties Liquidity and Uncertainties Liquidity And Uncertainties Disclosure Abstract 162M limitation Effective Income Tax Rate Reconciliation, 162M Limitation, Amount Effective income tax rate reconciliation, 162M limitation, amount. Sale of stock, price per share (in dollars per share) Sale of Stock, Price Per Share Interest income Investment Income, Interest Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Operating lease costs Operating Lease, Cost Common stock, issued (shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Issued Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Term charges on aggregate principal amount, percentage Line of Credit Facility, Commitment Fee Percentage Security Exchange Name Security Exchange Name Research and development credit Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount Long-term debt Long-term debt, gross Long-Term Debt Stock-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Sale of stock, consideration received on transaction Sale of Stock, Consideration Received on Transaction Accumulated other comprehensive income (loss) Accumulated Other Comprehensive Income (Loss), Net of Tax Common stock options Employee Stock Option [Member] Accrued interest payments, term Debt Instrument, Accrued Interest Payments, Term Debt Instrument, Accrued Interest Payments, Term Weighted average remaining period (in years) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Maximum Maximum [Member] Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Unrecognized stock compensation expense Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Document Type Document Type Tabular List, Table Tabular List [Table Text Block] Federal Domestic Tax Authority [Member] Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Stock-based Compensation Share-Based Payment Arrangement [Text Block] Purchases of marketable securities Payments to Acquire Debt Securities, Available-for-Sale Weighted average exercise price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Hoffmann-La Roche ("Roche") Hoffman La Roche [Member] Represents information pertaining to Hoffman-La Roche. Long term debt floor interest rate percentage Long Term Debt Floor Interest Rate Percentage Long term debt floor interest rate percentage. Operating loss carryforwards Operating Loss Carryforwards Variable Rate [Axis] Variable Rate [Axis] Loan Facility, Tranche 3 Loan Facility, Tranche Three [Member] Loan Facility, Tranche Three Cash Cash [Member] Income Statement [Abstract] Income Statement [Abstract] Cash, Cash Equivalents and Marketable Securities Schedule of Investments [Line Items] Issuance of common and preferred shares in equity offerings, excluding to related parties, net of transaction costs (in shares) Stock Issued During Period, Shares, New Issues Operating expenses: Costs and Expenses [Abstract] Options cancelled (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Title of 12(b) Security Title of 12(b) Security Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Related Party, Type [Domain] Related Party, Type [Domain] Accrued expenses Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Equity instruments other than options, weighted average grant date fair value (in dollars per share) Unvested, beginning balance (in USD per share) Unvested, ending balance (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Income Taxes Income Tax Disclosure [Abstract] Tax benefit at U.S. federal statutory rate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Share-Based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Entity Tax Identification Number Entity Tax Identification Number Performance-based restricted stock units Performance-Based Restricted Stock Units [Member] Performance-Based Restricted Stock Units Statistical Measurement [Axis] Statistical Measurement [Axis] Less amount representing interest Interest Expense, Debt, Excluding Amortization Financial Instrument [Axis] Financial Instrument [Axis] Entity Interactive Data Current Entity Interactive Data Current Total Shareholder Return Amount Total Shareholder Return Amount Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Supplemental disclosure of cash flow information: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Unrecognized stock-based compensation expense Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Valuation allowance on deferred tax assets (as a percent) Deferred Tax Assets, Percentage Of Valuation Allowance The percentage of valuation allowance on the deferred tax assets. Convertible Series A and B Preferred Stock Convertible Series A and B Preferred Stock [Member] Convertible Series A and B Preferred Stock [Member] Weighted average remaining contractual life (years) Share Based Compensation Arrangement by Share Based Payment Award, Options Outstanding Weighted Average Remaining Contractual Life [Abstract] Share Based Compensation Arrangement by Share Based Payment Award, Options Outstanding Weighted Average Remaining Contractual Life [Abstract] Accumulated deficit Retained Earnings (Accumulated Deficit) Measure: Measure [Axis] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Name Outstanding Recovery, Individual Name Research, Development and Commercialization Agreement Research Development And Commercialization Agreement [Member] Represents information pertaining to Research, Development and Commercialization Agreement with Hoffmann-La Roche ("Roche") which grants a sole and exclusive license to develop, use, sell, offer for sale and import any Licensed Product as defined by the agreement. Debt instrument, face amount Debt Instrument, Face Amount Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Current assets: Assets, Current [Abstract] Leases [Abstract] Leases [Abstract] Commitments and Contingencies Other Commitments [Line Items] Deferred Tax Assets Components of Deferred Tax Assets [Abstract] Schedule of Deferred Tax Assets and Liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Entity Address, State or Province Entity Address, State or Province Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Counterparty Name [Axis] Counterparty Name [Axis] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Anti-dilutive securities Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Operating lease payments Operating Lease, Payments Unrealized gain (loss) on available-for-sale securities OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax Common stock, outstanding (shares) Common Stock, Shares, Outstanding PEO PEO [Member] Auditor Location Auditor Location State income taxes benefit before valuation allowance, net of federal benefit Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount Proceeds from issuance of loan payable Proceeds from Bank Debt Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Sale of Stock [Axis] Sale of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities Other adjustments Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Debt Instrument [Axis] Debt Instrument [Axis] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Schedule of Quarterly Results of Operations Quarterly Financial Information [Table Text Block] Present value of lease liabilities Operating Lease, Liability Preferred stock conversion ratio (in shares) Conversion of Stock, Shares Converted Credit Facility [Axis] Credit Facility [Axis] Series B Preferred Stock Series B Preferred Stock [Member] Schedule of Maturities of Long-Term Debt Schedule of Maturities of Long-Term Debt [Table Text Block] Total liabilities Liabilities Organization, Business and Basis of Presentation Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Accumulated other comprehensive income (loss) AOCI Attributable to Parent [Member] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Fair value Cash, Cash Equivalents, and Short-Term Investments Common stock reserved for future issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance All Executive Categories All Executive Categories [Member] Long term liabilities: Liabilities, Noncurrent [Abstract] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Line of credit facility, number of withdrawals upon milestone achievements Line of Credit Facility, Number Of Withdrawals Upon Milestone Achievements Line of Credit Facility, Number Of Withdrawals Upon Milestone Achievements Plan Name [Axis] Plan Name [Axis] Expire In 2037 Expire In 2037 [Member] Expire in 2037. Accrued Liabilities Accounts Payable and Accrued Liabilities Disclosure [Text Block] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Net loss per common share: Earnings Per Share [Abstract] Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward] Marketable Securities Marketable Securities, Policy [Policy Text Block] Common stock, par value $0.0001 per share authorized: 200,000,000 at December 31, 2023 and December 31, 2022; 19,875,427 and 18,102,523 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively Common Stock, Value, Issued General and administrative General and Administrative Expense Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Professional fees Accrued Professional Fees, Current Option to increase or decrease ownership percentage, term Class Of Warrant Or Right, Beneficial Ownership, Exercise Percentage Notice Period Class Of Warrant Or Right, Beneficial Ownership, Exercise Percentage Notice Period Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Public Stock Offering Public Stock Offering [Member] Public Stock Offering 2021 Sales Agreement Two Thousand and Twenty One Sales Agreement [Member] Two thousand and twenty one sales agreement. Total current assets Assets, Current Cowen & Co. LLC Cowen Co. Llc [Member] Represent of Cowen & Co. LLC Member. Preferred stock Preferred Stock [Member] Inducement Plan 2023 Inducement Plan 2023 [Member] Inducement Plan 2023 All Individuals All Individuals [Member] Entity Filer Category Entity Filer Category Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Statement [Table] Statement [Table] Current Fiscal Year End Date Current Fiscal Year End Date Basic and Diluted Loss Per Common Share Earnings Per Share, Policy [Policy Text Block] Variable Rate Component Two Variable Rate Component Two [Member] Variable Rate Component Two Schedule of Effective Income Tax Rate Reconciliation Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Liability for uncertain tax positions Unrecognized Tax Benefits Cash, Cash Equivalents and Marketable Securities Cash, Cash Equivalents, and Marketable Securities [Text Block] Income Tax Authority [Axis] Income Tax Authority [Axis] PEO Name PEO Name Preferred stock, authorized (in shares) Preferred Stock, Shares Authorized Quarterly Financial Information Disclosure [Abstract] Quarterly Financial Information Disclosure [Abstract] Granted (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value US government and government sponsored entities due within 1 year of date of purchase (Level 2) US Treasury and Government [Member] Preferred stock, outstanding (in shares) Preferred Stock, Shares Outstanding Stock compensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Exercisable at the end of the year Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Class of Stock [Axis] Class of Stock [Axis] Compensation expense related to stock options for services APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Marketable securities Debt Securities, Available-for-Sale, Current Other Other Accrued Liabilities, Current Depreciation and amortization expense Depreciation, Depletion and Amortization Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Total stockholders’ equity Beginning balance Ending balance Equity, Attributable to Parent Stock Plan 2015 Stock Plan 2015 [Member] Stock Plan 2015 Valuation allowance Deferred Tax Assets, Valuation Allowance Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Income tax related interest and penalties Income Tax Examination, Penalties and Interest Expense Stock options, restricted stock and performance stock units convertible, shares issuable (in shares) Common Stock, Capital Shares Granted And Issuable Common Stock, Capital Shares Granted And Issuable Subsequent Events [Abstract] Subsequent Events [Abstract] Preferred stock, issued (in shares) Preferred Stock, Shares Issued Entity Emerging Growth Company Entity Emerging Growth Company Total deferred tax assets before valuation allowance Deferred Tax Assets, Gross Increase (Decrease) in Stockholders' Equity Increase (Decrease) in Stockholders' Equity [Roll Forward] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Document Fiscal Period Focus Document Fiscal Period Focus 2024 Lessee, Operating Lease, Liability, to be Paid, Year One Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Title Trading Arrangement, Individual Title Outstanding at the beginning of the year (in dollars per share) Outstanding at the end of the year (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Common stock Common Stock [Member] Individual: Individual [Axis] City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Income Statement Location [Domain] Income Statement Location [Domain] Patents Patents [Policy Text Block] Disclosure of accounting policy for patents. Document Fiscal Year Focus Document Fiscal Year Focus Property and equipment, net Property, Plant and Equipment, Net Summary of Significant Accounting Policies Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] Summary of stock option activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Exercise Price Award Exercise Price Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Assets Assets [Abstract] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Nonrelated Party Nonrelated Party [Member] Loan Facility, Tranche 1 Loan Facility, Tranche One [Member] Loan Facility, Tranche One Loan Facility Loan Facility [Member] Loan facility member. Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Accumulated deficit Retained Earnings [Member] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Total liabilities and stockholders’ equity Liabilities and Equity Cost Debt Securities, Available-for-Sale, Amortized Cost Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Richard Levy [Member] Richard Levy Basic net loss per common share (in dollars per share) Earnings Per Share, Basic Right-of-use asset Operating Lease, Right-of-Use Asset 2023 Sales Agreement Amendment Two Thousand And Twenty Three Sales Agreement Amendment [Member] Two Thousand And Twenty Three Sales Agreement [Member] Schedule of Long-Term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Accounting Policies [Abstract] Accounting Policies [Abstract] Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Sale of Stock [Domain] Sale of Stock [Domain] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Net deferred tax assets Deferred Tax Assets, Net Other clinical study related costs Accrued Other Clinical Study Related Costs Current Accrued other clinical study related costs current. Total intrinsic value of options exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Number of securities called by warrants (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Arrangement Duration Trading Arrangement Duration Other nondeductible expenses Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount Entity Address, City or Town Entity Address, City or Town Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Related Party Related Party [Member] Principle of Consolidation Consolidation, Policy [Policy Text Block] Total long term liabilities Liabilities, Noncurrent Proceeds from issuance of debt Proceeds from Issuance of Debt Document Transition Report Document Transition Report Award Timing Predetermined Award Timing Predetermined [Flag] Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Termination Date Trading Arrangement Termination Date Common stock, authorized (in shares) Common Stock, Shares Authorized Fair value Debt Securities, Available-for-Sale Entity Public Float Entity Public Float Unrealized gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Increase in valuation allowance Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Loans payable, net of discount Long-Term Debt, Gross Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] All Trading Arrangements All Trading Arrangements [Member] All Adjustments to Compensation All Adjustments to Compensation [Member] Award Timing Disclosures [Line Items] Compensation Amount Outstanding Recovery Compensation Amount Other comprehensive income (loss): Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Forfeited (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Proceeds resulting from exercise of stock options Proceeds from Stock Options Exercised Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Options cancelled (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Income Taxes Income Tax, Policy [Policy Text Block] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Document Financial Statement Error Correction [Flag] Document Financial Statement Error Correction [Flag] Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Variable Rate Component [Axis] Variable Rate Component [Axis] Variable Rate Component Insider Trading Arrangements [Line Items] 2024 Long-Term Debt, Maturity, Year One Related Party, Type [Axis] Related Party, Type [Axis] Outstanding at the end of the year Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Entity Registrant Name Entity Registrant Name Other income Other Nonoperating Income Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Award Timing Method Award Timing Method [Text Block] Warrants and rights outstanding Warrants and Rights Outstanding Remainder of future milestone payments Remaining Milestone Payments The amount of future milestone payments remaining to be paid under the agreement. Adjustment to Compensation, Amount Adjustment to Compensation Amount Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] Deferred Tax Liabilities Components of Deferred Tax Liabilities [Abstract] Auditor Name Auditor Name Document Period End Date Document Period End Date Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Adoption Date Trading Arrangement Adoption Date Exercisable at the end of the year (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Entity Central Index Key Entity Central Index Key Amortization of debt issuance costs and discount Amortization of Debt Issuance Costs and Discounts Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Loan Facility, Tranche 2 Loan Facility, Tranche Two [Member] Loan Facility, Tranche Two Stock-based compensation expense Share-Based Payment Arrangement, Expense Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Income tax expense (benefit) Income Tax Expense (Benefit) Income Tax Authority [Domain] Income Tax Authority [Domain] Sale of stock, maximum required percentage of ownership after transaction Class Of Warrant Or Right, Beneficial Ownership, Maximum Threshold Class Of Warrant Or Right, Beneficial Ownership, Maximum Threshold Compensation and benefits Employee-related Liabilities, Current Name Trading Arrangement, Individual Name Cash and Cash Equivalents [Abstract] Cash and Cash Equivalents [Abstract] Charitable contributions Deferred Tax Assets, Charitable Contribution Carryforwards Issuance of common shares in equity offering, excluding to related parties, net of transaction costs Stock Issued During Period, Value, New Issues Equity [Abstract] Weighted average, operating lease term Operating Lease, Weighted Average Remaining Lease Term Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Long-Term Debt, Type [Axis] Long-Term Debt, Type [Axis] Amendment Flag Amendment Flag Money market funds Money Market Funds [Member] Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Intangibles Deferred Tax Assets, Goodwill and Intangible Assets Unrealized gains on investments Deferred Tax Liabilities, Unrealized Gains on Trading Securities Research and development tax credit carryforwards Tax Credit Carryforward, Amount Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Tax Period [Domain] Tax Period [Domain] Weighted average, operating discount rate Operating Lease, Weighted Average Discount Rate, Percent Credit Facility [Domain] Credit Facility [Domain] Basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Loan payable, net of discount Long-Term Debt, Excluding Current Maturities Diluted weighted average number of common shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Diluted Contract research organization costs Accrued Contract Research Costs Current Accrued Contract Research Costs, Current. Accrued interest, net of interest received on maturity of investments Increase (Decrease) In Accrued Interest, Net Of Interest Received The increase (decrease) during the reporting period in the aggregate amount of accrued interest expense incurred but not yet paid, net of interest received on maturity of investments. Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Marketable securities, realized gain (loss) Debt Securities, Available-for-Sale, Realized Gain (Loss) Purchases of property and equipment, net of disposals Payments to Acquire Property, Plant, and Equipment Company Selected Measure Amount Company Selected Measure Amount Additional paid-in-capital Additional Paid in Capital, Common Stock Additional paid-in Capital Additional Paid-in Capital [Member] Document Annual Report Document Annual Report Maximum aggregate offering price Common Stock Aggregate Offering Price Represents the maximum aggregate offering price the entity may issue and sell shares of its common stock from time to time, at the entity's option, according to at-the-market issuance sales agreement with third party. Becky Taub [Member] Becky Taub 2022 Registered Direct Offering Two Thousand and Twenty Two Registered Direct Offering [Member] Two Thousand and Twenty Two Registered Direct Offering [Member] Total assets Assets Name Awards Close in Time to MNPI Disclosures, Individual Name Cover [Abstract] Cover [Abstract] Pre-Funded Warrants Pre-Funded Warrants [Member] Pre-Funded Warrants Subsequent Event Subsequent Events [Text Block] Tax Period [Axis] Tax Period [Axis] Line of credit facility, decrease In maximum borrowing capacity Line Of Credit Facility, Decrease In Maximum Borrowing Capacity Line Of Credit Facility, Decrease In Maximum Borrowing Capacity Vested (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Non-NEOs Non-NEOs [Member] Total minimum payments Lessee, Operating Lease, Liability, to be Paid Operating Leases Operating Lease, Liability [Abstract] Subsidiary, Sale of Stock [Line Items] Subsidiary, Sale of Stock [Line Items] Total operating expenses Operating Expenses Prime Rate Prime Rate [Member] Net increase (decrease) in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Secured Debt Secured Debt [Member] Non-PEO NEO Non-PEO NEO [Member] Equity Component [Domain] Equity Component [Domain] Adjustment to Compensation: Adjustment to Compensation [Axis] State State and Local Jurisdiction [Member] R&D credit Deferred Tax Assets, Tax Credit Carryforwards, Research Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Net operating losses Deferred Tax Assets, Operating Loss Carryforwards Debt Instrument [Line Items] Debt Instrument [Line Items] Basic weighted average number of common shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Basic Property, plant & equipment Deferred Tax Assets, Property, Plant and Equipment Entity Current Reporting Status Entity Current Reporting Status Variable Rate Component [Domain] Variable Rate Component [Domain] Variable Rate Component [Domain] Loss from operations Operating Income (Loss) Revenues: Revenues [Abstract] Total Deferred Tax Liabilities Deferred Tax Liabilities, Gross Preferred shares number voting rights Preferred Stock, Number Of Voting Rights Number of voting rights of preferred stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights. Stockholders' Equity (Deficit) Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Statement Statement [Line Items] Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table]